ALK fusions are observed in ∼4% of NSCLC patients (8), resulting from an inversion ofEML4 and ALK gene on the short arm of chromosome 2which constitutively activates the kinase and protein oligomerization (9). Here, ALK is linked to non-small cell lung carcinoma.